Crescent Biopharma (CBIO) Reiterated at Overweight by Cantor Fitzgerald

June 23, 2026 7:16 AM

Cantor Fitzgerald analyst Eric Schmidt reiterated an Overweight rating on Crescent Biopharma Inc (NASDAQ: CBIO).The analyst commented, "After the close ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found